Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations.
Thoracic cancer（2023）
摘要
Patients with TTF-1-negative and EGFR-mutant LUAD show a diminished response to EGFR-TKIs.
更多查看译文
关键词
efficacy, EGFR tyrosine kinase inhibitor, epidermal growth factor receptor, lung adenocarcinoma, thyroid transcription factor 1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要